DIMENSIONAL FUND ADVISORS LP - SYNAGEVA BIOPHARMA CORP ownership

SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 88 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q1 2015$4,034,000
+40240.0%
41,356
+39665.4%
0.00%
Q4 2014$10,000
+42.9%
1040.0%0.00%
Q3 2014$7,000
-99.2%
104
-98.8%
0.00%
-100.0%
Q2 2014$927,000
+140.8%
8,851
+90.5%
0.00%
Q1 2014$385,000
+654.9%
4,645
+491.0%
0.00%
Q4 2013$51,000
-96.1%
786
-96.2%
0.00%
-100.0%
Q3 2013$1,299,000
-46.2%
20,512
-64.3%
0.00%
-50.0%
Q2 2013$2,416,00057,5120.00%
Other shareholders
SYNAGEVA BIOPHARMA CORP shareholders Q2 2013
NameSharesValueWeighting ↓
Baker Brothers Advisors 10,660,432$1,117,213,00013.68%
BB BIOTECH AG 898,476$94,160,0004.47%
SECTORAL ASSET MANAGEMENT INC 516,445$54,123,0002.29%
Ghost Tree Capital, LLC 30,000$3,144,0002.22%
COLUMBIA WANGER ASSET MANAGEMENT LLC 3,521,000$369,001,0001.48%
Pier Capital, LLC 83,493$8,750,0001.24%
ArrowMark Colorado Holdings LLC 197,613$20,710,0000.59%
PALISADE CAPITAL MANAGEMENT, LP 120,779$12,658,0000.31%
FORTALEZA ASSET MANAGEMENT INC/ 5,440$570,0000.26%
Tradeworx Inc. 2,936$308,0000.25%
View complete list of SYNAGEVA BIOPHARMA CORP shareholders